Cytokinetics incorporated ticker

Author: moas

August undefined, 2024

WebMar 24, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential... WebApr 10, 2024 · Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. About the company Rewards Revenue is forecast to grow 46.65% per year Risk Analysis Negative shareholders equity

79 ETFs with Cytokinetics, Incorporated (CYTK) exposure ETF.com

WebApr 29, 2004 · Cytokinetics, Inc. 350 Oyster Point Blvd South San Francisco, CA 94080 Phone: 650-624-3060 Fax: 650-624-3070 Email: ... WebFeb 17, 2024 · It is currently -18.08% from its 52-week high and 51.01% from its 52-week low. How much is Cytokinetics stock worth today? ( NASDAQ: CYTK) Cytokinetics currently has 94,631,001 outstanding shares. With Cytokinetics stock trading at $45.71 per share, the total value of Cytokinetics stock (market capitalization) is $4.33B. can be found in plant cells

Cytokinetics Muscle Biology Therapies Home

WebOperating Status Active. Last Funding Type Post-IPO Debt. Legal Name Cytokinetics, Inc. Stock Symbol NASDAQ:CYTK. Company Type For Profit. Contact Email [email protected]. Phone Number … WebCytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company... WebCytokinetics Incorporated 280 East Grand Avenue South San Francisco, CA 94080 United States. Website. Investor relation . Ratios; Stock Price Chart; Annual Returns; … can be found in the attachment

Is Cytokinetics, Incorporated (CYTK) A Good Stock …

INVESTOR FAQ Cytokinetics, Inc.

WebCytokinetics, Incorporated is a company in the U.S. stock market and it is a holding in 79 U.S.-traded ETFs. CYTK has around 18.7M shares in the U.S. ETF market. WebTicker Total employees 2024 revenue Percent of revenue from government sales Headquarters 15 Serco Inc. 12930 Worldgate Dr. #600 Herndon, VA 20240 703-263 … can be found at the following linkWebCytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance. Stock Information. Press Releases. In the News. Calendar. … can be found in spanish

"WebHeadquarters United States of America Address ., 280 East Grand Avenue, South San Francisco, California, 94080 Website cytokinetics.com Telephone 1 650 6243000 No of Employees 253 Industry Pharmaceuticals and Healthcare Ticker Symbol & Exchange CYTK (NASD) Revenue (2024) $70.4M 26.2% (2024 vs 2024) EPS XXX " - Cytokinetics incorporated ticker

Cytokinetics incorporated ticker

WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. WebApr 6, 2024 · CYTK Cytokinetics, Incorporated Stock Price & Overview $35.39 -0.79 ( -2.18%) 1:21 PM 03/22/23 NASDAQ $USD Realtime Summary Ratings Financials …

Did you know?

WebSelected key stats of Cytokinetics, Incorporated (CYTK) including 10 year stock price and latest news. Key stats provide selected financials for rapid company overview including revenues, marketcap, P/E ratio, debt and much more.

WebWho is Cytokinetics Headquarters 350 Oyster Point Blvd, South San Francisco, California, 94080, United States Phone Number (650) 624-3000 Website www.cytokinetics.com … WebWho is Cytokinetics Headquarters 350 Oyster Point Blvd, South San Francisco, California, 94080, United States Phone Number (650) 624-3000 Website www.cytokinetics.com Revenue $65M Stock Symbol CYTK Industry Pharmaceuticals Healthcare Cytokinetics's Social Media Is this data correct? View contact profiles from Cytokinetics Popular …

WebAug 24, 2016 · Today's investors are interested in making a statement while earning a return. WebApr 6, 2024 · Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as …

WebDec 30, 2024 · Cytokinetics, Incorporated is a late-stage biopharmaceutical company. It is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for debilitating diseases. It is developing small molecule drug candidates specifically engineered to impact muscle function and contractility.

WebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. can be found in the beginningWebDescription. Developer of diagnostic therapeutics drug designed to improve the treatment of painful osteoarthritis, back, and joint pain. The company's drug offers a Fibronectin-Aggrecan Complex Test for molecular discography and a multi-analyte assay for diagnosing the source of pain in the spine and joints for identification of a naturally ... fishing dbnWebMar 16, 2024 · Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle … fishing days perthWebApr 5, 2024 · SEC FILINGS Cytokinetics, Inc. INVESTORS & MEDIA SEC FILINGS SEC Filing Keyword Search Group Filing year Items per page 10 1 2 3 4 5 6 7 8 9 … Next › Last » Displaying 1 - 10 of 1887 results Mar 02 2024 2:55 pm EST Data Provided by Refinitiv. Minimum 15 minutes delayed. STOCK CHART fishing daytona beachWebTicker. IPOs; Earnings Search Calendar Annual Comparison Quarterly Comparison Quarterly Range Growth Rate Sector View Earnings Averages P/E Ratio Annual Fiscal … can be found in the browser title barWebAnalysis of Cytokinetics Incorporated's forth quarter 2024 to forth quarter 2024 EBITDA Margin, ranking within Major Pharmaceutical Preparations industry and Healthcare Sector, EBITDA and Revenue quarterly change - CSIMarket can be found or findWebDec 10, 2024 · Cytokinetics, Incorporated (NASDAQ: CYTK) has seen an increase in hedge fund interest recently. Our calculations also showed that CYTK isn't among the 30 most popular stocks among hedge funds... fishing dayz